25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANI Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze ANI Pharmaceuticals Inc together

I guess you are interested in ANI Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ANI Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ANI Pharmaceuticals Inc

I send you an email if I find something interesting about ANI Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of ANI Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of ANI Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.08
When do you have the money?
1 year
How often do you get paid?
37.5%

What is your share worth?

Current worth
$20.50
Expected worth in 1 year
$19.36
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
$-1.06
Return On Investment
-1.8%

For what price can you sell your share?

Current Price per Share
$57.87
Expected price per share
$53.47 - $64.21
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of ANI Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$57.87
Intrinsic Value Per Share
$23.16 - $85.48
Total Value Per Share
$43.66 - $105.98

2.2. Growth of ANI Pharmaceuticals Inc (5 min.)




Is ANI Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$430.7m$391.8m$51m11.5%

How much money is ANI Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.7m$3.3m-$5.1m-288.7%
Net Profit Margin-1.0%2.4%--

How much money comes from the company's main activities?

2.3. Financial Health of ANI Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of ANI Pharmaceuticals Inc?

Welcome investor! ANI Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of ANI Pharmaceuticals Inc.

First you should know what it really means to hold a share of ANI Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of ANI Pharmaceuticals Inc is $57.87. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ANI Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ANI Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $20.50. Based on the TTM, the Book Value Change Per Share is $-0.28 per quarter. Based on the YOY, the Book Value Change Per Share is $1.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ANI Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.15-2.0%-0.08-0.1%0.140.2%-0.26-0.5%-0.05-0.1%
Usd Book Value Change Per Share-1.19-2.1%-0.28-0.5%1.402.4%0.520.9%0.390.7%
Usd Dividend Per Share0.020.0%0.020.0%0.020.0%0.010.0%0.010.0%
Usd Total Gains Per Share-1.17-2.0%-0.27-0.5%1.422.5%0.530.9%0.400.7%
Usd Price Per Share59.66-61.90-47.96-43.57-50.47-
Price to Earnings Ratio-12.97-27.88-58.93-132.28-122.09-
Price-to-Total Gains Ratio-51.06-71.90-265.61-91.85-372.51-
Price to Book Ratio2.91-2.94-2.56-3.07-5.00-
Price-to-Total Gains Ratio-51.06-71.90-265.61-91.85-372.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share57.87
Number of shares17
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share-0.280.52
Usd Total Gains Per Share-0.270.53
Gains per Quarter (17 shares)-4.519.01
Gains per Year (17 shares)-18.0336.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-19-2813526
23-39-4627062
34-58-64310698
45-77-823141134
57-97-1004176170
68-116-1185211206
79-135-1366246242
811-155-1547282278
912-174-1728317314
1013-193-1908352350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%5.07.00.041.7%7.013.00.035.0%25.015.00.062.5%31.068.00.031.3%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%10.010.00.050.0%29.011.00.072.5%52.046.01.052.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%15.00.05.075.0%15.00.025.037.5%15.00.084.015.2%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%11.09.00.055.0%30.010.00.075.0%53.045.01.053.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ANI Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.188-0.284-76%1.404-185%0.518-329%0.394-401%
Book Value Per Share--20.49721.069-3%18.641+10%14.987+37%11.649+76%
Current Ratio--2.7453.558-23%3.450-20%3.031-9%5.165-47%
Debt To Asset Ratio--0.6650.549+21%0.524+27%0.554+20%0.529+26%
Debt To Equity Ratio--1.9881.281+55%1.109+79%1.261+58%1.147+73%
Dividend Per Share--0.0190.0190%0.0190%0.012+55%0.006+211%
Eps---1.150-0.084-93%0.145-895%-0.262-77%-0.053-95%
Free Cash Flow Per Share--1.0231.048-2%0.630+62%0.074+1287%-0.111+111%
Free Cash Flow To Equity Per Share--14.8704.116+261%1.568+849%1.322+1025%0.716+1978%
Gross Profit Margin--1.0001.0000%1.0000%1.297-23%1.308-24%
Intrinsic Value_10Y_max--85.484--------
Intrinsic Value_10Y_min--23.163--------
Intrinsic Value_1Y_max--2.442--------
Intrinsic Value_1Y_min--0.026--------
Intrinsic Value_3Y_max--12.005--------
Intrinsic Value_3Y_min--2.066--------
Intrinsic Value_5Y_max--27.195--------
Intrinsic Value_5Y_min--6.270--------
Market Cap1216300086.000-3%1253921948.0001301054364.500-4%1008013688.000+24%915808599.400+37%1060865573.325+18%
Net Profit Margin---0.163-0.010-94%0.024-769%-0.094-42%0.013-1311%
Operating Margin---0.1970.005-4212%0.093-312%-0.053-73%0.089-321%
Operating Ratio--1.5641.087+44%0.901+74%1.066+47%0.912+71%
Pb Ratio2.823-3%2.9112.935-1%2.561+14%3.074-5%5.002-42%
Pe Ratio-12.583+3%-12.97227.880-147%58.930-122%132.283-110%122.092-111%
Price Per Share57.870-3%59.66061.903-4%47.960+24%43.573+37%50.475+18%
Price To Free Cash Flow Ratio14.140-3%14.57818.543-21%3.615+303%2.788+423%-1717.924+11885%
Price To Total Gains Ratio-49.532+3%-51.06471.899-171%265.609-119%91.847-156%372.509-114%
Quick Ratio--1.7972.626-32%2.392-25%2.075-13%4.085-56%
Return On Assets---0.0190.000-100%0.004-610%-0.009-54%0.001-2259%
Return On Equity---0.056-0.005-92%0.007-903%-0.021-63%-0.001-99%
Total Gains Per Share---1.168-0.265-77%1.423-182%0.530-320%0.400-392%
Usd Book Value--430798000.000442817500.000-3%391801250.000+10%315004000.000+37%244845175.000+76%
Usd Book Value Change Per Share---1.188-0.284-76%1.404-185%0.518-329%0.394-401%
Usd Book Value Per Share--20.49721.069-3%18.641+10%14.987+37%11.649+76%
Usd Dividend Per Share--0.0190.0190%0.0190%0.012+55%0.006+211%
Usd Eps---1.150-0.084-93%0.145-895%-0.262-77%-0.053-95%
Usd Free Cash Flow--21504000.00022029500.000-2%13236250.000+62%1550250.000+1287%-2333950.000+111%
Usd Free Cash Flow Per Share--1.0231.048-2%0.630+62%0.074+1287%-0.111+111%
Usd Free Cash Flow To Equity Per Share--14.8704.116+261%1.568+849%1.322+1025%0.716+1978%
Usd Market Cap1216300086.000-3%1253921948.0001301054364.500-4%1008013688.000+24%915808599.400+37%1060865573.325+18%
Usd Price Per Share57.870-3%59.66061.903-4%47.960+24%43.573+37%50.475+18%
Usd Profit---24166000.000-1772750.000-93%3345250.000-822%-5368300.000-78%-1056725.000-96%
Usd Revenue--148332000.000138864000.000+7%112348500.000+32%84979000.000+75%61564000.000+141%
Usd Total Gains Per Share---1.168-0.265-77%1.423-182%0.530-320%0.400-392%
 EOD+4 -4MRQTTM+7 -28YOY+13 -225Y+16 -2010Y+16 -20

3.3 Fundamental Score

Let's check the fundamental score of ANI Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.583
Price to Book Ratio (EOD)Between0-12.823
Net Profit Margin (MRQ)Greater than0-0.163
Operating Margin (MRQ)Greater than0-0.197
Quick Ratio (MRQ)Greater than11.797
Current Ratio (MRQ)Greater than12.745
Debt to Asset Ratio (MRQ)Less than10.665
Debt to Equity Ratio (MRQ)Less than11.988
Return on Equity (MRQ)Greater than0.15-0.056
Return on Assets (MRQ)Greater than0.05-0.019
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of ANI Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.622
Ma 20Greater thanMa 5057.970
Ma 50Greater thanMa 10058.187
Ma 100Greater thanMa 20059.623
OpenGreater thanClose57.180
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Fundamental data was last updated by Penke on 2024-11-14 10:09:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit ANI Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -16.3% means that $-0.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ANI Pharmaceuticals Inc:

  • The MRQ is -16.3%. The company is making a huge loss. -2
  • The TTM is -1.0%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-1.0%-15.3%
TTM-1.0%YOY2.4%-3.4%
TTM-1.0%5Y-9.4%+8.4%
5Y-9.4%10Y1.3%-10.7%
4.3.1.2. Return on Assets

Shows how efficient ANI Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.9% Return on Assets means that ANI Pharmaceuticals Inc generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ANI Pharmaceuticals Inc:

  • The MRQ is -1.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.9%TTM0.0%-1.9%
TTM0.0%YOY0.4%-0.4%
TTM0.0%5Y-0.9%+0.9%
5Y-0.9%10Y0.1%-0.9%
4.3.1.3. Return on Equity

Shows how efficient ANI Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -5.6% Return on Equity means ANI Pharmaceuticals Inc generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ANI Pharmaceuticals Inc:

  • The MRQ is -5.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.6%TTM-0.5%-5.2%
TTM-0.5%YOY0.7%-1.2%
TTM-0.5%5Y-2.1%+1.6%
5Y-2.1%10Y-0.1%-2.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ANI Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient ANI Pharmaceuticals Inc is operating .

  • Measures how much profit ANI Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -19.7% means the company generated $-0.20  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ANI Pharmaceuticals Inc:

  • The MRQ is -19.7%. The company is operating very inefficient. -2
  • The TTM is 0.5%. The company is operating inefficient. -1
Trends
Current periodCompared to+/- 
MRQ-19.7%TTM0.5%-20.1%
TTM0.5%YOY9.3%-8.8%
TTM0.5%5Y-5.3%+5.8%
5Y-5.3%10Y8.9%-14.2%
4.3.2.2. Operating Ratio

Measures how efficient ANI Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.56 means that the operating costs are $1.56 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 1.564. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.087. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.564TTM1.087+0.477
TTM1.087YOY0.901+0.186
TTM1.0875Y1.066+0.021
5Y1.06610Y0.912+0.153
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ANI Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if ANI Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.74 means the company has $2.74 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 2.745. The company is able to pay all its short-term debts. +1
  • The TTM is 3.558. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.745TTM3.558-0.813
TTM3.558YOY3.450+0.108
TTM3.5585Y3.031+0.527
5Y3.03110Y5.165-2.134
4.4.3.2. Quick Ratio

Measures if ANI Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.80 means the company can pay off $1.80 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 1.797. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.626. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.797TTM2.626-0.829
TTM2.626YOY2.392+0.234
TTM2.6265Y2.075+0.551
5Y2.07510Y4.085-2.010
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ANI Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of ANI Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ANI Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.67 means that ANI Pharmaceuticals Inc assets are financed with 66.5% credit (debt) and the remaining percentage (100% - 66.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 0.665. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.549. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.665TTM0.549+0.116
TTM0.549YOY0.524+0.026
TTM0.5495Y0.554-0.004
5Y0.55410Y0.529+0.025
4.5.4.2. Debt to Equity Ratio

Measures if ANI Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 198.8% means that company has $1.99 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 1.988. The company is just able to pay all its debts with equity.
  • The TTM is 1.281. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.988TTM1.281+0.708
TTM1.281YOY1.109+0.172
TTM1.2815Y1.261+0.019
5Y1.26110Y1.147+0.114
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings ANI Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -12.97 means the investor is paying $-12.97 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ANI Pharmaceuticals Inc:

  • The EOD is -12.583. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.972. Based on the earnings, the company is expensive. -2
  • The TTM is 27.880. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-12.583MRQ-12.972+0.389
MRQ-12.972TTM27.880-40.852
TTM27.880YOY58.930-31.050
TTM27.8805Y132.283-104.403
5Y132.28310Y122.092+10.191
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ANI Pharmaceuticals Inc:

  • The EOD is 14.140. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 14.578. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 18.543. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.140MRQ14.578-0.437
MRQ14.578TTM18.543-3.966
TTM18.543YOY3.615+14.929
TTM18.5435Y2.788+15.756
5Y2.78810Y-1,717.924+1,720.712
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of ANI Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of ANI Pharmaceuticals Inc:

  • The EOD is 2.823. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.911. Based on the equity, the company is underpriced. +1
  • The TTM is 2.935. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.823MRQ2.911-0.087
MRQ2.911TTM2.935-0.024
TTM2.935YOY2.561+0.374
TTM2.9355Y3.074-0.139
5Y3.07410Y5.002-1.928
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of ANI Pharmaceuticals Inc.

4.8.1. Institutions holding ANI Pharmaceuticals Inc

Institutions are holding 89.565% of the shares of ANI Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc12.60810.003826565151251724.9449
2024-06-30Vanguard Group Inc6.83650.0018144044413401210.2579
2024-06-30State Street Corp3.06190.00186451457030712.2308
2024-06-30Dimensional Fund Advisors, Inc.2.99110.0105630226210533.456
2024-06-30Rubric Capital Management LP2.86571.0082603800-354733-37.0079
2024-09-30Ranger Investment Management LP2.79872.257558968818695446.4212
2024-06-30Morgan Stanley - Brokerage Accounts2.56610.0013540678361587.1668
2024-06-30Global Alpha Capital Management Ltd.2.5012.44652695013620034.856
2024-06-30William Blair Investment Management, LLC2.32270.0818489386-879-0.1793
2024-06-30Deep Track Capital, LP2.21210.8859466089-355912-43.2982
2024-06-30TANG CAPITAL MANAGEMENT LLC2.13582.9185450000300000200
2024-06-30Geode Capital Management, LLC1.9360.00234079116854720.1987
2024-06-30Macquarie Group Ltd1.84190.028338807717417881.43
2024-06-30Citadel Advisors Llc1.74820.0048368339319509654.3293
2024-06-30Nuveen Asset Management, LLC1.51470.00593191427298629.6503
2024-06-30Amvescap Plc.1.47650.0042311091-12951-3.9967
2024-06-30Charles Schwab Investment Management Inc1.14610.00292414774499422.8997
2024-06-30Ameriprise Financial Inc1.10750.004233354-9920-4.0777
2024-06-30Millennium Management LLC1.0920.00682300792092721005.7769
2024-06-30JPMorgan Chase & Co1.01560.0011213981-18209-7.8423
Total 55.77829.677411752372+1146738+9.8%

4.9.2. Funds holding ANI Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31iShares Core S&P Small-Cap ETF5.01940.0717105758811040.1045
2024-09-30Vanguard Total Stock Mkt Idx Inv2.79190.00258825300
2024-10-31Pacer US Small Cap Cash Cows 100 ETF2.63740.3704555702-143-0.0257
2024-10-31iShares Russell 2000 ETF2.23130.0397470136-1064-0.2258
2024-09-30Ranger Small Cap1.86131.749939217815203563.3102
2024-09-30Delaware Ivy Small Cap Growth C1.59661.536933639600
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr1.16730.01352459551330.0541
2024-09-30CC&L Global Alpha - Series A1.14141.2158240500-14900-5.834
2024-08-31Fidelity Small Cap Index0.89750.0442189097-5226-2.6893
2024-09-30William Blair Small Cap Value I0.86890.82183086-2374-1.2801
2024-10-31iShares S&P Small-Cap 600 Growth ETF0.76390.146616095100
2024-03-31Ranger Micro Cap0.73964.111715583126351.72
2024-10-31Invesco Pharmaceuticals ETF0.70073.009614763900
2024-10-31SPDR® Portfolio S&P 600™ Sm Cap ETF0.69410.07114625411200.7717
2024-09-30Nuveen Quant Small Cap Equity R60.59830.21412606000
2024-08-31CREF Stock R10.59530.0062125420-15900-11.2511
2024-10-31Global Alpha Global Small Cap0.56441.238411891100
2024-09-30Vanguard Tax-Managed Small Cap Adm0.55950.072611788844513.9238
2024-10-31iShares Russell 2000 Growth ETF0.54910.055811568800
2024-09-30Kennedy Small Cap Value0.50830.81751071071366514.624
Total 26.486215.60755580640+135536+2.4%

5.3. Insider Transactions

Insiders are holding 11.155% of the shares of ANI Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-10-14Meredith CookSELL25057.19
2024-09-13Meredith CookSELL25056.82
2024-08-13Meredith CookSELL25059.62
2024-07-17Muthusamy ShanmugamSELL1425763.16
2024-07-15Muthusamy ShanmugamSELL1100063.38
2024-07-12Meredith CookSELL25064.91
2024-07-01Chad GassertSELL2000063.44
2024-06-21Muthusamy ShanmugamSELL2000058.9
2024-06-13Meredith CookSELL25063.8
2024-06-05Ori GutwergSELL298567
2024-06-04Stephen P CareySELL500063.58
2024-06-03Chad GassertSELL2000064.41
2024-05-21Christopher MutzSELL200061.61
2024-05-20Muthusamy ShanmugamSELL1285561.81
2024-05-17Muthusamy ShanmugamSELL583662.09
2024-05-16Renee P TannenbaumSELL200063.87
2024-05-15Muthusamy ShanmugamSELL1485065.86
2024-05-14Nikhil LalwaniSELL1666966.1
2024-05-13Meredith CookSELL25067.69
2024-05-01Chad GassertSELL2000066.62
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
EBIT  14,527-5,8168,7116,34415,055-9,5275,528-34,695-29,167
EBITDA  30,561-6,65623,9055,83629,741-9,51620,225-33,644-13,419
Operating Income  17,948-9,2378,7116,34415,055-9,5275,528-26,047-20,519



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,287,377
Total Liabilities856,579
Total Stockholder Equity430,798
 As reported
Total Liabilities 856,579
Total Stockholder Equity+ 430,798
Total Assets = 1,287,377

Assets

Total Assets1,287,377
Total Current Assets521,297
Long-term Assets766,080
Total Current Assets
Cash And Cash Equivalents 144,982
Net Receivables 196,361
Inventory 148,042
Other Current Assets 23,614
Total Current Assets  (as reported)521,297
Total Current Assets  (calculated)512,999
+/- 8,298
Long-term Assets
Property Plant Equipment 56,704
Goodwill 60,426
Intangible Assets 569,825
Long-term Assets Other 11,464
Long-term Assets  (as reported)766,080
Long-term Assets  (calculated)698,419
+/- 67,661

Liabilities & Shareholders' Equity

Total Current Liabilities189,933
Long-term Liabilities666,646
Total Stockholder Equity430,798
Total Current Liabilities
Short-term Debt 7,152
Accounts payable 60,890
Other Current Liabilities 115,787
Total Current Liabilities  (as reported)189,933
Total Current Liabilities  (calculated)183,829
+/- 6,104
Long-term Liabilities
Long-term Liabilities  (as reported)666,646
Long-term Liabilities  (calculated)0
+/- 666,646
Total Stockholder Equity
Common Stock2
Retained Earnings -89,597
Accumulated Other Comprehensive Income 5,366
Other Stockholders Equity 490,177
Total Stockholder Equity (as reported)430,798
Total Stockholder Equity (calculated)405,948
+/- 24,850
Other
Cash and Short Term Investments 144,982
Common Stock Shares Outstanding 19,404
Current Deferred Revenue6,104
Liabilities and Stockholders Equity 1,287,377
Net Debt 480,381
Net Working Capital 331,364
Short Long Term Debt Total 625,363



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-06-30
> Total Assets 
0
5,291
3,831
3,725
3,067
5,637
5,210
6,491
4,979
4,979
2,142
5,781
5,880
3,934
2,740
10,897
9,565
8,671
23,349
21,070
17,827
15,206
12,493
10,784
9,575
7,483
4,903
10,735
22,371
19,048
35,155
33,415
31,241
28,717
24,330
19,822
17,679
13,216
9,529
15,959
36,437
47,316
51,783
40,763
44,767
56,805
42,764
74,891
62,380
54,575
47,295
43,212
38,769
35,356
41,658
43,286
44,500
96,652
95,423
107,637
263,709
265,985
270,121
283,276
285,265
291,588
307,999
319,379
322,864
357,138
359,219
370,469
412,138
418,019
424,177
439,443
430,604
434,390
446,906
456,775
456,789
482,232
465,391
462,581
461,190
463,843
480,159
470,454
771,598
744,846
751,334
739,110
760,087
765,224
859,341
889,914
904,422
914,524
920,753
1,287,377
1,287,377920,753914,524904,422889,914859,341765,224760,087739,110751,334744,846771,598470,454480,159463,843461,190462,581465,391482,232456,789456,775446,906434,390430,604439,443424,177418,019412,138370,469359,219357,138322,864319,379307,999291,588285,265283,276270,121265,985263,709107,63795,42396,65244,50043,28641,65835,35638,76943,21247,29554,57562,38074,89142,76456,80544,76740,76351,78347,31636,43715,9599,52913,21617,67919,82224,33028,71731,24133,41535,15519,04822,37110,7354,9037,4839,57510,78412,49315,20617,82721,07023,3498,6719,56510,8972,7403,9345,8805,7812,1424,9794,9796,4915,2105,6373,0673,7253,8315,2910
   > Total Current Assets 
0
4,858
3,405
3,321
2,676
5,268
4,845
6,094
4,594
4,594
1,777
5,430
5,548
3,625
2,455
10,631
9,318
8,416
23,088
20,825
17,578
14,954
12,251
10,565
9,347
7,283
4,713
10,540
22,208
18,919
35,071
33,346
31,007
27,945
23,454
18,552
16,087
11,652
7,733
14,219
31,410
42,452
47,318
36,677
40,625
52,487
38,139
70,544
58,026
50,191
42,930
38,583
35,173
31,927
24,119
26,095
27,716
67,936
67,160
57,565
203,478
202,993
208,948
197,522
192,583
116,552
79,824
95,475
103,007
106,981
112,856
125,582
131,605
143,394
152,367
156,793
152,877
151,832
168,912
182,386
187,695
158,662
156,544
165,819
170,321
182,798
191,799
191,384
321,775
301,399
322,399
309,377
344,261
364,753
459,311
497,220
519,616
540,557
555,160
521,297
521,297555,160540,557519,616497,220459,311364,753344,261309,377322,399301,399321,775191,384191,799182,798170,321165,819156,544158,662187,695182,386168,912151,832152,877156,793152,367143,394131,605125,582112,856106,981103,00795,47579,824116,552192,583197,522208,948202,993203,47857,56567,16067,93627,71626,09524,11931,92735,17338,58342,93050,19158,02670,54438,13952,48740,62536,67747,31842,45231,41014,2197,73311,65216,08718,55223,45427,94531,00733,34635,07118,91922,20810,5404,7137,2839,34710,56512,25114,95417,57820,82523,0888,4169,31810,6312,4553,6255,5485,4301,7774,5944,5946,0944,8455,2682,6763,3213,4054,8580
       Cash And Cash Equivalents 
0
4,812
3,366
3,235
2,612
5,222
4,782
5,979
4,502
4,502
1,704
5,258
4,884
3,412
2,335
10,396
9,134
8,262
22,973
20,576
1,170
56
380
254
311
70
134
366
7,654
11,291
27,382
25,403
15,649
13,106
10,326
5,701
11,761
10,162
5,986
13,169
29,858
41,163
46,382
35,526
38,155
51,349
37,126
69,600
57,225
49,474
42,417
38,049
34,794
29,389
12,595
10,930
11,105
51,373
52,961
35,050
169,037
165,563
166,731
150,913
154,684
77,747
15,014
16,155
27,365
10,826
8,369
18,031
31,144
51,970
54,994
44,136
43,008
38,233
40,589
59,673
62,332
20,414
27,702
17,900
7,864
25,073
24,261
15,254
100,300
76,911
63,385
56,281
48,228
67,757
161,707
193,078
221,121
228,597
240,110
144,982
144,982240,110228,597221,121193,078161,70767,75748,22856,28163,38576,911100,30015,25424,26125,0737,86417,90027,70220,41462,33259,67340,58938,23343,00844,13654,99451,97031,14418,0318,36910,82627,36516,15515,01477,747154,684150,913166,731165,563169,03735,05052,96151,37311,10510,93012,59529,38934,79438,04942,41749,47457,22569,60037,12651,34938,15535,52646,38241,16329,85813,1695,98610,16211,7615,70110,32613,10615,64925,40327,38211,2917,65436613470311254380561,17020,57622,9738,2629,13410,3962,3353,4124,8845,2581,7044,5024,5025,9794,7825,2222,6123,2353,3664,8120
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,099
14,693
11,693
10,045
8,791
6,985
4,372
9,904
3,796
3,857
3,904
3,953
15,006
14,472
12,430
11,770
3,026
3,026
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,260
2,260
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,655
6,943
0
06,9439,655000000000000000000000000000000000000000002,2602,26000000000000000003,0263,02611,77012,43014,47215,0063,9533,9043,8573,7969,9044,3726,9858,79110,04511,69314,69316,09900000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,511
3,515
3,577
3,600
15
30
21
83
230
357
117
38
65
133
53
0
0
0
0
0
0
0
0
0
5,432
5,904
6,428
9,515
12,513
10,907
7,794
14,570
17,297
17,371
18,880
21,645
21,932
22,481
35,562
47,477
45,895
46,697
55,513
62,174
58,788
54,801
56,115
67,647
64,842
67,410
76,274
70,700
72,129
82,379
73,162
83,745
95,793
91,876
92,648
106,714
128,526
131,625
150,410
140,433
165,438
174,713
172,925
178,842
162,079
172,418
166,091
196,361
196,361166,091172,418162,079178,842172,925174,713165,438140,433150,410131,625128,526106,71492,64891,87695,79383,74573,16282,37972,12970,70076,27467,41064,84267,64756,11554,80158,78862,17455,51346,69745,89547,47735,56222,48121,93221,64518,88017,37117,29714,5707,79410,90712,5139,5156,4285,9045,432000000000531336538117357230832130153,6003,5773,51510,5110000000000000000000000000000
       Other Current Assets 
0
45
39
86
64
46
63
115
0
92
72
172
520
65
120
235
183
154
115
249
310
205
178
266
245
228
208
270
248
257
208
391
337
336
677
998
1,070
1,133
1,630
1,011
1,487
1,157
883
1,151
2,470
1,138
1,013
944
801
717
513
534
379
278
252
581
27,716
566
493
599
1,983
1,546
1,615
1,985
1,453
1,252
4,046
2,653
3,564
3,565
2,676
4,847
2,784
2,267
1,768
5,004
4,524
4,157
3,311
5,025
3,995
2,967
3,117
3,358
5,861
5,922
4,881
4,702
7,589
9,708
16,059
16,770
8,387
6,874
8,248
10,690
25,220
16,050
16,568
23,614
23,61416,56816,05025,22010,6908,2486,8748,38716,77016,0599,7087,5894,7024,8815,9225,8613,3583,1172,9673,9955,0253,3114,1574,5245,0041,7682,2672,7844,8472,6763,5653,5642,6534,0461,2521,4531,9851,6151,5461,98359949356627,7165812522783795345137178019441,0131,1382,4701,1518831,1571,4871,0111,6301,1331,07099867733633739120825724827020822824526617820531024911515418323512065520172729201156346648639450
   > Long-term Assets 
0
434
425
404
391
369
365
397
0
385
365
351
332
308
285
266
248
255
261
245
249
252
242
219
228
201
190
195
162
129
84
69
234
773
876
1,270
1,592
1,564
1,796
1,740
5,027
4,864
4,465
4,086
4,142
4,319
4,625
4,347
4,353
4,384
4,365
4,629
3,596
3,430
17,539
17,191
16,784
28,716
28,263
50,072
60,231
62,992
61,173
85,754
92,682
175,036
228,175
223,904
219,857
250,157
246,363
244,887
280,533
274,625
271,810
282,650
277,727
282,558
277,994
274,389
269,094
323,570
308,847
296,762
290,869
281,045
288,360
279,070
449,823
443,447
428,935
429,733
415,826
400,471
400,030
392,694
384,806
373,967
365,593
766,080
766,080365,593373,967384,806392,694400,030400,471415,826429,733428,935443,447449,823279,070288,360281,045290,869296,762308,847323,570269,094274,389277,994282,558277,727282,650271,810274,625280,533244,887246,363250,157219,857223,904228,175175,03692,68285,75461,17362,99260,23150,07228,26328,71616,78417,19117,5393,4303,5964,6294,3654,3844,3534,3474,6254,3194,1424,0864,4654,8645,0271,7401,7961,5641,5921,270876773234698412916219519020122821924225224924526125524826628530833235136538503973653693914044254340
       Property Plant Equipment 
0
434
425
404
391
369
365
397
385
385
365
351
332
308
285
266
248
255
261
245
249
252
242
219
216
189
165
170
137
104
59
44
55
60
162
529
815
786
753
720
748
710
684
647
636
813
1,133
855
861
884
862
1,185
166
4,855
4,741
4,640
4,537
4,518
4,625
5,046
5,223
5,281
5,249
5,833
7,131
8,415
8,911
9,716
10,998
12,897
14,966
17,387
20,403
21,882
22,842
37,418
38,090
38,425
38,953
39,754
40,551
40,353
39,937
40,444
41,269
40,767
40,334
39,526
52,671
52,713
43,771
42,830
43,246
43,275
44,371
44,189
44,593
48,526
51,640
56,704
56,70451,64048,52644,59344,18944,37143,27543,24642,83043,77152,71352,67139,52640,33440,76741,26940,44439,93740,35340,55139,75438,95338,42538,09037,41822,84221,88220,40317,38714,96612,89710,9989,7168,9118,4157,1315,8335,2495,2815,2235,0464,6254,5184,5374,6404,7414,8551661,1858628848618551,133813636647684710748720753786815529162605544591041371701651892162192422522492452612552482662853083323513653853853973653693914044254340
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
4,180
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
27,888
28,188
28,221
28,221
28,221
28,221
28,221
28,221
28,221
28,221
28,221
60,426
60,42628,22128,22128,22128,22128,22128,22128,22128,22128,22128,18827,8883,5803,5803,5803,5803,5803,5803,5803,5803,5803,5803,5803,5804,1801,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,838000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,406
3,406
3,406
3,414
3,414
3,414
3,414
3,414
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000700300000000000000000000003,4143,4143,4143,4143,4143,4063,4063,4060000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
73
10,960
10,712
10,409
22,360
21,800
43,188
42,067
45,408
44,174
68,291
66,397
147,386
194,674
188,949
175,792
203,459
196,624
189,829
229,790
221,917
217,484
209,544
201,604
205,100
196,697
188,372
180,388
215,619
205,745
198,620
188,511
178,859
180,199
170,141
294,122
281,573
269,593
264,237
251,635
238,791
230,299
219,828
209,009
196,044
183,078
569,825
569,825183,078196,044209,009219,828230,299238,791251,635264,237269,593281,573294,122170,141180,199178,859188,511198,620205,745215,619180,388188,372196,697205,100201,604209,544217,484221,917229,790189,829196,624203,459175,792188,949194,674147,38666,39768,29144,17445,40842,06743,18821,80022,36010,40910,71210,96073850000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
302
0
12,798
12,550
12,247
24,198
23,638
45,026
55,008
57,711
55,924
79,921
85,551
166,621
219,264
214,188
208,859
237,260
231,397
227,500
260,130
28,988
29,346
30,808
34,453
35,453
38,764
42,683
44,575
64,018
59,585
54,118
57,509
57,839
64,247
65,823
75,142
80,573
83,750
85,045
92,724
90,184
87,939
0
0
0
0
0
0000087,93990,18492,72485,04583,75080,57375,14265,82364,24757,83957,50954,11859,58564,01844,57542,68338,76435,45334,45330,80829,34628,988260,130227,500231,397237,260208,859214,188219,264166,62185,55179,92155,92457,71155,00845,02623,63824,19812,24712,55012,79803020000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,796
7,369
7,027
7,118
17,316
17,397
17,751
18,400
26,227
26,962
27,933
30,829
22,667
23,163
23,590
25,082
27,964
28,542
31,957
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000031,95728,54227,96425,08223,59023,16322,66730,82927,93326,96226,22718,40017,75117,39717,3167,1187,0277,3697,796000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
286
247
697
941
795
941
1,029
928
928
736
693
1,256
555
721
700
881
1,147
1,176
1,336
1,907
1,811
1,551
1,607
2,756
2,790
2,325
1,706
4,300
2,431
2,611
2,235
1,516
2,927
3,621
4,570
3,853
3,105
3,717
4,777
20,607
24,310
25,158
25,459
25,620
30,669
31,233
30,742
24,564
16,579
16,374
10,922
10,594
9,326
6,163
6,597
3,538
4,560
3,828
8,145
123,924
121,245
120,621
127,383
125,183
131,410
144,223
150,549
153,216
184,926
182,673
187,668
237,382
238,375
239,067
246,978
233,341
234,678
239,250
243,645
243,998
281,061
274,047
267,481
265,490
260,131
288,242
279,051
412,858
398,752
414,376
402,435
421,547
425,742
424,869
435,203
471,673
462,561
464,993
856,579
856,579464,993462,561471,673435,203424,869425,742421,547402,435414,376398,752412,858279,051288,242260,131265,490267,481274,047281,061243,998243,645239,250234,678233,341246,978239,067238,375237,382187,668182,673184,926153,216150,549144,223131,410125,183127,383120,621121,245123,9248,1453,8284,5603,5386,5976,1639,32610,59410,92216,37416,57924,56430,74231,23330,66925,62025,45925,15824,31020,6074,7773,7173,1053,8534,5703,6212,9271,5162,2352,6112,4314,3001,7062,3252,7902,7561,6071,5511,8111,9071,3361,1761,1478817007215551,2566937369289281,0299417959416972472860
   > Total Current Liabilities 
0
286
247
697
941
795
941
1,029
928
928
736
693
1,256
555
721
700
881
1,147
1,176
1,336
1,907
1,811
1,551
1,505
2,666
2,735
2,304
1,663
4,300
2,431
2,611
2,235
1,516
2,927
3,621
4,570
3,853
3,105
3,717
4,777
3,930
6,225
6,690
7,095
8,183
12,633
11,481
11,500
7,228
6,085
16,374
10,922
10,594
9,326
6,163
6,597
3,538
4,560
3,828
8,145
13,233
9,073
6,949
12,190
11,756
16,211
24,730
30,491
31,948
32,425
28,292
36,384
39,228
39,650
39,678
46,902
165,549
165,068
166,794
170,707
61,676
79,356
79,088
75,900
78,565
82,768
89,454
84,872
87,537
79,532
96,312
81,627
99,439
125,825
122,865
134,352
145,477
136,889
139,978
189,933
189,933139,978136,889145,477134,352122,865125,82599,43981,62796,31279,53287,53784,87289,45482,76878,56575,90079,08879,35661,676170,707166,794165,068165,54946,90239,67839,65039,22836,38428,29232,42531,94830,49124,73016,21111,75612,1906,9499,07313,2338,1453,8284,5603,5386,5976,1639,32610,59410,92216,3746,0857,22811,50011,48112,6338,1837,0956,6906,2253,9304,7773,7173,1053,8534,5703,6212,9271,5162,2352,6112,4314,3001,6632,3042,7352,6661,5051,5511,8111,9071,3361,1761,1478817007215551,2566937369289281,0299417959416972472860
       Short-term Debt 
0
0
0
500
500
500
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
640
0
0
0
434
465
796
776
795
614
0
0
0
0
0
0
0
0
0
0
1,111
1,150
1,187
1,234
0
0
10,478
7,593
7,884
8,169
4,115
4,332
1,326
1,013
1,133
0
106,540
0
0
0
113,427
0
0
0
120,643
152,501
154,381
151,284
3,353
3,805
5,217
5,692
115,719
117,393
120,007
121,740
9,941
11,872
12,329
12,785
13,243
14,438
15,182
15,927
850
850
850
850
850
850
850
850
850
850
850
7,152
7,15285085085085085085085085085085085015,92715,18214,43813,24312,78512,32911,8729,941121,740120,007117,393115,7195,6925,2173,8053,353151,284154,381152,501120,643000113,427000106,54001,1331,0131,3264,3324,1158,1697,8847,59310,478001,2341,1871,1501,111000000000061479577679646543400064000000000000000000500500500500000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106,540
0
0
0
113,427
0
0
0
120,643
152,501
154,381
151,284
3,353
3,805
5,217
5,692
115,719
117,393
120,007
121,740
9,941
11,872
12,329
12,785
13,243
14,438
15,182
15,927
850
850
850
850
850
850
850
850
850
850
850
0
085085085085085085085085085085085015,92715,18214,43813,24312,78512,32911,8729,941121,740120,007117,393115,7195,6925,2173,8053,353151,284154,381152,501120,643000113,427000106,540000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
101
111
68
45
93
194
100
0
91
287
529
471
248
479
272
239
376
608
856
1,169
1,053
782
518
1,140
1,380
670
318
622
644
889
559
711
2,301
2,620
3,420
3,182
2,429
2,550
3,529
2,440
4,003
4,719
4,523
4,864
8,504
6,349
6,042
3,151
3,282
3,836
2,005
1,129
164
1,635
2,087
1,429
2,660
1,731
3,059
2,654
2,288
1,325
2,633
2,066
3,040
4,961
4,730
3,389
4,785
3,153
5,821
3,630
4,886
7,949
7,257
8,884
10,519
9,809
10,953
14,606
12,485
14,209
13,460
11,261
13,769
12,977
11,513
22,967
22,059
27,641
18,992
29,305
32,687
28,505
34,077
36,683
49,430
48,681
60,890
60,89048,68149,43036,68334,07728,50532,68729,30518,99227,64122,05922,96711,51312,97713,76911,26113,46014,20912,48514,60610,9539,80910,5198,8847,2577,9494,8863,6305,8213,1534,7853,3894,7304,9613,0402,0662,6331,3252,2882,6543,0591,7312,6601,4292,0871,6351641,1292,0053,8363,2823,1516,0426,3498,5044,8644,5234,7194,0032,4403,5292,5502,4293,1823,4202,6202,3017115598896446223186701,3801,1405187821,0531,1698566083762392724792484715292879101001949345681111010
       Other Current Liabilities 
0
185
136
129
397
201
247
929
0
837
448
164
785
307
242
428
642
771
568
480
738
758
768
850
750
1,218
1,498
1,242
3,176
1,288
899
881
1
7
1,001
1,146
671
675
1,166
1,248
1,490
2,222
1,971
2,572
2,208
2,979
5,133
4,224
4,077
2,803
2,060
1,324
1,581
992
366
132
736
849
951
5,066
10,579
6,785
5,624
9,557
9,690
13,171
19,769
25,761
28,559
27,640
25,139
30,563
8,274
9,020
9,764
33,218
40,235
36,532
36,420
37,518
36,678
54,681
52,425
49,543
53,981
54,499
61,233
57,370
63,633
56,507
67,821
61,785
69,284
92,288
89,422
23,939
54,933
14,375
36,032
115,787
115,78736,03214,37554,93323,93989,42292,28869,28461,78567,82156,50763,63357,37061,23354,49953,98149,54352,42554,68136,67837,51836,42036,53240,23533,2189,7649,0208,27430,56325,13927,64028,55925,76119,76913,1719,6909,5575,6246,78510,5795,0669518497361323669921,5811,3242,0602,8034,0774,2245,1332,9792,2082,5721,9712,2221,4901,2481,1666756711,1461,001718818991,2883,1761,2421,4981,21875085076875873848056877164242824230778516444883709292472013971291361850
   > Long-term Liabilities 
0
0
0
92,136
0
0
0
27,401
0
24,444
61,277
33,487
0
0
0
0
0
0
0
0
0
0
0
102
90
56
22
43
0
0
0
0
0
0
0
0
0
0
0
0
16,676
18,085
18,467
18,364
17,436
18,037
19,752
19,242
17,337
10,494
12,538
8,917
0
0
0
0
0
0
0
0
110,691
112,172
113,672
115,193
113,427
115,199
119,493
120,058
121,268
152,501
154,381
151,284
198,154
198,725
199,389
200,076
67,792
69,610
72,456
72,938
182,322
201,705
194,959
191,581
186,925
177,363
198,788
194,179
325,321
319,220
318,064
320,808
322,108
299,917
302,004
300,851
326,196
325,672
325,015
666,646
666,646325,015325,672326,196300,851302,004299,917322,108320,808318,064319,220325,321194,179198,788177,363186,925191,581194,959201,705182,32272,93872,45669,61067,792200,076199,389198,725198,154151,284154,381152,501121,268120,058119,493115,199113,427115,193113,672112,172110,691000000008,91712,53810,49417,33719,24219,75218,03717,43618,36418,46718,08516,676000000000000432256901020000000000033,48761,27724,444027,40100092,136000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,752
19,242
17,337
10,494
0
0
0
0
0
0
0
0
0
0
0
0
113,672
115,193
0
0
116,993
118,808
120,643
152,501
154,381
151,284
128,208
130,156
199,389
200,076
67,296
66,501
65,688
64,873
175,808
188,094
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000188,094175,80864,87365,68866,50167,296200,076199,389130,156128,208151,284154,381152,501120,643118,808116,99300115,193113,67200000000000010,49417,33719,24219,7520000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,796
7,369
7,027
7,118
17,316
17,397
17,751
18,400
26,227
26,962
27,933
30,829
22,667
23,163
23,590
25,082
27,964
28,542
31,957
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000031,95728,54227,96425,08223,59023,16322,66730,82927,93326,96226,22718,40017,75117,39717,3167,1187,0277,3697,796000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,850
24,850
24,850
24,850
24,850
24,850
24,850
0
0
0
0
0
0000024,85024,85024,85024,85024,85024,85024,8500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
625
0
0
0
625
0
2,500
1,250
625
0
0
0
0
0
0
0
496
0
6,768
2
7
0
1
200
201
6
0
0
31,016
32,053
30,970
33,445
35,058
13,258
12,029
0
0
0
0
0
0000012,02913,25835,05833,44530,97032,05331,01600620120010726,768049600000006251,2502,5000625000625000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
829
823
749
700
1,468
1,300
1,300
1,200
800
700
600
600
500
400
400
300
800
800
700
700
600
0
500
0
0
0
0
0
0000050006007007008008003004004005006006007008001,2001,3001,3001,468700749823829000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
5,005
3,583
3,028
2,126
4,843
4,269
5,462
0
4,051
1,406
5,088
4,624
3,379
2,019
10,197
8,684
7,525
22,173
19,734
15,921
13,395
10,942
9,177
6,819
4,693
2,578
9,029
18,071
16,618
32,545
31,181
29,725
25,791
20,708
15,252
13,826
10,111
5,813
11,182
15,830
23,006
26,626
15,304
19,147
26,136
11,531
44,149
37,815
37,996
30,921
32,290
28,176
26,031
35,495
36,689
40,962
92,092
91,595
99,492
139,785
144,740
149,500
155,893
160,082
160,178
163,776
168,830
169,648
172,212
176,546
182,801
174,756
179,644
185,110
192,465
197,263
199,712
207,656
213,130
212,791
201,171
191,344
195,100
195,700
203,712
191,917
191,403
358,740
346,094
336,958
336,675
338,540
339,482
434,472
454,711
432,749
451,963
455,760
430,798
430,798455,760451,963432,749454,711434,472339,482338,540336,675336,958346,094358,740191,403191,917203,712195,700195,100191,344201,171212,791213,130207,656199,712197,263192,465185,110179,644174,756182,801176,546172,212169,648168,830163,776160,178160,082155,893149,500144,740139,78599,49291,59592,09240,96236,68935,49526,03128,17632,29030,92137,99637,81544,14911,53126,13619,14715,30426,62623,00615,83011,1825,81310,11113,82615,25220,70825,79129,72531,18132,54516,61818,0719,0292,5784,6936,8199,17710,94213,39515,92119,73422,1737,5258,68410,1972,0193,3794,6245,0881,4064,05105,4624,2694,8432,1263,0283,5835,0050
   Common Stock
0
17,663
17,676
17,741
17,783
17,783
21,458
22,301
0
22,303
22,256
26,738
26,685
26,685
26,942
36,559
36,705
37,991
55,214
55,644
56,456
56,613
56,654
56,654
56,654
57,668
57,719
64,916
64,968
65,332
83,659
83,988
84,207
84,501
84,864
85,565
85,733
86,068
86,391
98,130
135,264
152,980
167,394
167,662
184,777
209,017
209,387
254,739
255,054
265,500
265,769
273,259
273,132
273,278
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2222221111111111111111111111111111111111111111273,278273,132273,259265,769265,500255,054254,739209,387209,017184,777167,662167,394152,980135,26498,13086,39186,06885,73385,56584,86484,50184,20783,98883,65965,33264,96864,91657,71957,66856,65456,65456,65456,61356,45655,64455,21437,99136,70536,55926,94226,68526,68526,73822,25622,303022,30121,45817,78317,78317,74117,67617,6630
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-197,857
-210,590
-217,239
-227,504
-234,848
-240,970
-244,957
-247,248
-53,096
-51,904
-48,472
-45,113
-47,476
-40,730
-19,725
-15,356
-11,785
-7,226
-4,350
-5,504
-4,379
-1,836
-2,916
-1,778
903
5,623
-4,006
-1,756
1,021
6,058
11,488
11,939
18,524
22,419
17,584
10,565
-1,771
-1,337
-4,972
-4,886
-18,992
-23,439
-47,765
-68,300
-83,630
-92,636
-97,286
-96,252
-90,414
0
0
0
0
0
00000-90,414-96,252-97,286-92,636-83,630-68,300-47,765-23,439-18,992-4,886-4,972-1,337-1,77110,56517,58422,41918,52411,93911,4886,0581,021-1,756-4,0065,623903-1,778-2,916-1,836-4,379-5,504-4,350-7,226-11,785-15,356-19,725-40,730-47,476-45,113-48,472-51,904-53,096-247,248-244,957-240,970-234,848-227,504-217,239-210,590-197,8570000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-208
-232
-257
-18
3,389
-282
-282
-375
-375
-375
-375
-467
-467
-467
-467
-560
-560
-560
-560
-662
-410
-322
-662
-146
-59
-763
-763
-769
-769
-769
-769
-237
-602
-237
428
-210
-210
0
0
-347
-347
0
-15,303,788
-446
-26,136
-11,531
-44,149
-426
-37,996
0
0
-392
0
-2,929
-3,063
-3,197
-3,334
-3,480
-3,633
-3,794
-3,962
-4,143
-4,257
-4,450
-4,667
-4,894
-5,135
-5,387
-5,704
-5,970
-6,274
-6,589
-6,658
216
533
-379
-2,199
-5,013
-6,037
-4,871
-11,689
-14,049
-13,110
-11,437
-5,032
-5,433
-4,235
-3,055
2,712
5,430
10,039
12,168
11,131
13,726
14,076
8,857
9,406
8,328
5,366
5,3668,3289,4068,85714,07613,72611,13112,16810,0395,4302,712-3,055-4,235-5,433-5,032-11,437-13,110-14,049-11,689-4,871-6,037-5,013-2,199-379533216-6,658-6,589-6,274-5,970-5,704-5,387-5,135-4,894-4,667-4,450-4,257-4,143-3,962-3,794-3,633-3,480-3,334-3,197-3,063-2,9290-39200-37,996-426-44,149-11,531-26,136-446-15,303,7880-347-34700-210-210428-237-602-237-769-769-769-769-763-763-59-146-662-322-410-662-560-560-560-560-467-467-467-467-375-375-375-375-282-2823,389-18-257-232-2080
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89,022
89,025
89,501
137,272
139,070
140,221
159,509
160,095
161,397
163,118
164,431
165,681
168,154
170,665
172,563
173,989
175,901
177,436
179,020
181,649
184,531
186,532
186,812
189,971
194,867
197,470
200,800
203,505
209,409
211,792
214,354
216,223
219,403
222,211
387,844
391,084
395,043
399,396
403,901
408,395
495,488
0
0
0
0
0
00000495,488408,395403,901399,396395,043391,084387,844222,211219,403216,223214,354211,792209,409203,505200,800197,470194,867189,971186,812186,532184,531181,649179,020177,436175,901173,989172,563170,665168,154165,681164,431163,118161,397160,095159,509140,221139,070137,27289,50189,02589,022000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000-1,211-723-723-7230-659-659-659-250-259-259-2590000000-1130000-68-68-433-433000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
208
232
257
264
3,671
282
282
0
375
375
375
467
467
467
467
560
560
560
560
662
0
0
662
0
0
763
763
769
769
769
769
237
0
237
0
209
0
0
0
347
0
0
15,303,788
446
26,136
11,531
44,149
426
37,996
0
0
391
0
91,518
91,655
92,630
140,538
142,550
143,854
163,303
164,057
165,427
167,375
168,881
170,348
173,048
175,800
177,950
179,693
181,612
183,451
185,350
188,057
183,872
185,873
186,153
189,971
194,144
196,747
200,077
202,294
207,163
209,546
212,108
213,629
216,341
219,076
384,709
386,831
390,307
394,421
398,807
399,752
486,308
496,663
479,172
480,036
487,605
490,177
490,177487,605480,036479,172496,663486,308399,752398,807394,421390,307386,831384,709219,076216,341213,629212,108209,546207,163202,294200,077196,747194,144189,971186,153185,873183,872188,057185,350183,451181,612179,693177,950175,800173,048170,348168,881167,375165,427164,057163,303143,854142,550140,53892,63091,65591,51803910037,99642644,14911,53126,13644615,303,7880034700020902370237769769769769763763006620066256056056056046746746746737537537502822823,6712642572322080



5.4. Balance Sheets

Currency in USD. All numbers in thousands.